Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 3
1992 6
1993 4
1994 2
1995 1
1996 4
1998 2
1999 4
2000 4
2001 5
2002 3
2003 3
2004 9
2005 7
2007 5
2008 6
2009 6
2010 7
2011 6
2012 3
2013 9
2014 6
2015 9
2016 6
2017 9
2018 5
2019 15
2020 10
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, Derocq D, Robin G, Michaud HA, Delpech H, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Simony-Lafontaine J, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget JP, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E. Ashraf Y, et al. Among authors: pelegrin a. J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z. J Immunother Cancer. 2019. PMID: 30717773 Free PMC article.
[A word from the coordinators].
Pèlegrin A, Beck A, Watier H. Pèlegrin A, et al. Med Sci (Paris). 2019 Dec;35(12):923. doi: 10.1051/medsci/2019245. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903894 Free article. French. No abstract available.
[Antibodies, tools of choice for fluorescence-guided surgery].
Pèlegrin A, Gutowski M, Cailler F. Pèlegrin A, et al. Med Sci (Paris). 2019 Dec;35(12):1066-1071. doi: 10.1051/medsci/2019207. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903919 Free article. Review. French.
Pseudomonas aeruginosa: a clinical and genomics update.
Pelegrin AC, Palmieri M, Mirande C, Oliver A, Moons P, Goossens H, van Belkum A. Pelegrin AC, et al. FEMS Microbiol Rev. 2021 Nov 23;45(6):fuab026. doi: 10.1093/femsre/fuab026. FEMS Microbiol Rev. 2021. PMID: 33970247
[Players from the program "Investments for the Future": MAbImprove MabEx].
Larivière M, Pèlegrin A, Martineau P, Watier H. Larivière M, et al. Among authors: pelegrin a. Med Sci (Paris). 2019 Dec;35(12):1204-1205. doi: 10.1051/medsci/2019249. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903941 Free article. Review. French. No abstract available.
[Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I. Ladjemi MZ, et al. Among authors: pelegrin a. Pathol Biol (Paris). 2011 Jun;59(3):173-82. doi: 10.1016/j.patbio.2009.04.002. Epub 2009 May 28. Pathol Biol (Paris). 2011. PMID: 19481373 Free article. Review. French.
[Bispecific antibodies: what future?].
Pèlegrin A, Robert B. Pèlegrin A, et al. Med Sci (Paris). 2009 Dec;25(12):1155-8. doi: 10.1051/medsci/200925121155. Med Sci (Paris). 2009. PMID: 20035697 Free article. Review. French.
Clinical radioimmunotherapy--the role of radiobiology.
Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, Azria D. Pouget JP, et al. Among authors: pelegrin a. Nat Rev Clin Oncol. 2011 Nov 8;8(12):720-34. doi: 10.1038/nrclinonc.2011.160. Nat Rev Clin Oncol. 2011. PMID: 22064461 Review.
General overview of radioimmunotherapy of solid tumors.
Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP. Navarro-Teulon I, et al. Among authors: pelegrin a. Immunotherapy. 2013 May;5(5):467-87. doi: 10.2217/imt.13.34. Immunotherapy. 2013. PMID: 23638743 Review.
157 results